Skip to content
Screener

Lucid Diagnostics LUCD Q1 2026 earnings

Reported May 14, 2026 · Before market open

Revenue$1.3MMiss by $124.3K
EPS-$0.07Miss by $0.02
Revenue estimate$1.4M
EPS estimate-$0.05

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$1.7M
EPS estimate-$0.04

Financials

Q1 2026

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$195.92M+44.9%
Enterprise value$169.64M+50.8%
P/S38.2×+5.8×

Profitability

See full
Operating margin-959.6%-133pp
Net margin-876.7%-254pp

Returns & leverage

See full
Debt / equity0.4×—
Current ratio1.1×+0.3×

FAQ

When did Lucid Diagnostics report Q1 2026 earnings?
Lucid Diagnostics (LUCD) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Lucid Diagnostics's Q1 2026 revenue and EPS?
Lucid Diagnostics reported revenue of $1.3M and eps of $-0.07 for Q1 2026.
Did Lucid Diagnostics beat estimates in Q1 2026?
Revenue missed the consensus estimate of $1.4M by $124.3K. EPS missed the consensus estimate of $-0.05 by $0.02.
How did Lucid Diagnostics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 51.7% from $828.0K a year earlier and eps grew 56.3% from $-0.16.
Where can I find Lucid Diagnostics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-022877) and the 10-Q periodic report (0001437749-26-016751) directly on SEC EDGAR. The filing index links above go to sec.gov.